SUMMARY Lymphocytes from patients with various diseases associated with autoimmunity showed both impaired capacity to repair O"-methylguanine (a powerful, promutagenic, directly miscoding base lesion) and increased sensitivity to the cytocidal effects of cellular methylation by N-methyl-N-nitrosourea (MNU) compared with normal controls and patients with other disorders. Defective repair of O'-methylguanine was significantly associated with arthritis and myositis in the group with systemic lupus erythematosus (SLE), and increased sensitivity to the toxic action of MNU was associated with the presence of immune complexes and the administration of steroids to patients with Behqet's syndrome. The results indicate that lymphocytes from patients with the autoimmune diseases studied are more susceptible to DNA damage with possible relevance to aetiopathogenesis.
cytes from healthy human donors are relatively proficient.) This repair activity has been studied in cells from patients with autoimmune diseases and they also showed evidence of defective DNA repair.3
This paper assesses DNA repair in a larger population of people with autoimmune diseases and examines the results in relation to the clinical features of the diseases.
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Patients and methods P A T I E N T S
A total of 245 individuails were studied in the following categories: (a) Systemic lupus erythematosus (SLE). Forty eight patients satisfying Arthritis and Rheumatism Association criteria. 4 Disease duraition was four months to 38 years (mean 8-2 years).
(b) Rheumatoid arthritis (RA). Twenty one patients satisfying the diagnostic criteria of Ropes et al. ' Disease duration was two months to 2() years (mean 6-4 years The ENDs from all the autoimmune disease groups were taken together and put into numerical order and divided into three equal groups, to allow comparison between groups I and III ( Table 2) . The results in patients with autoimmune disease showed a wide range of values, but significant numbers showed increased cellular sensitivity to the toxic action of MNU (Table 2) .
Clinical features and laboratory results were analysed in relation to these toxicity studies (Table   3 ). Behqet's syndrome. The ENDs were calculated and the results were grouped as indicated in the text.
. Fig. 3 shows the products of methylation of blood lymphocyte DNA with ['4CIMNU in the chromatogram from a patient with SLE one hour after initial exposure. There was deficiency of O"-MeGua repair while 3-methyladenine was proficiently removed. The removal of 7-MeGua was slow and there was no Fig. 3 this value was 0-088.
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Control donors had generally lower ratios than the other groups, indicating more proficient repair of 06-MeGua (Fig. 4) . Significant differences were found between the healthy control group and donors with Behqet's syndrome, SLE, RA, and the group of miscellaneous autoimmune diseases but not scleroderma (Table 4) .
When repair proficiency of 06-MeGua was analysed in terms of specific clinical and laboratory findings arthritis in the group with SLE, myositis in the group with miscellaneous autoimmune diseases, and disease activity in the group with RA were significantly associated with reduced 06-MeGua repair (Table 5) . 
